海胆黄多糖SEP对S180的体内抑制作用

研究海胆黄多糖SEP对S180肉瘤的抑制作用及初步机制。MTT法检测SEP对体外培养的S180细胞生长的抑制作用;建立小鼠S180肉瘤模型观察SEP抗肿瘤活性;检测SEP协同ConA/LPS刺激小鼠脾淋巴细胞增殖作用;同时,考察SEP对NK细胞和杀伤性T淋巴细胞(cytotoxic T lym-phocyte,CTL)活性的影响;碳粒廓清检测SEP对小鼠单核巨噬细胞吞噬功能的影响。研究表明,海胆黄多糖SEP高中低剂量(16、8、4 mg/kg)显著抑制小鼠180实体瘤生长,增加小鼠脾指数和胸腺指数,协同ConA/LPS刺激小鼠脾淋巴细胞增殖,提高小鼠NK细胞和CTL活性,增强小鼠单核巨噬细胞的吞噬功能,通过免疫调节提高小鼠免疫功能达到抑制S180作用。     

红毛五加多糖不同组分对小鼠腹腔巨噬细胞免疫功能的研究

本文研究红毛五加多糖不同组分(AHP-I、AHP-II、AHP-III)对小鼠腹腔巨噬细胞免疫调节功能的影响,为进一步阐明红毛五加多糖对小鼠免疫调节作用机制奠定基础。采用不同浓度的3种多糖组分作用于小鼠腹腔巨噬细胞,测定其对巨噬细胞吞噬中性红、释放NO能力、分泌IL-6、TNF-α、IL-1β水平的影响。最后结果是红毛五加多糖的3种不同组分对小鼠免疫细胞有不同的刺激能力。其中,AHP-II可极其显著地增强吞噬细胞的吞噬功能,促进其合成NO,促进巨噬细胞细胞因子的分泌。因此红毛五加多糖能激活小鼠腹腔巨噬细胞,其中,AHP-II是最重要的作用组分。     

鳞柄小奥德蘑多糖对巨噬细胞免疫功能的调节作用

研究鳞柄小奥德蘑多糖对小鼠巨噬细胞的免疫调节作用。采用灌洗腹腔法收集小鼠巨噬细胞,建立其体外培养体系;采用鸡血红细胞法、荧光探针标记、总一氧化氮检测和酶联免疫吸附试验等方法分别检测巨噬细胞吞噬能力、NO合成量、肿瘤坏死因子-α、白细胞介素-1、白细胞介素-6和白细胞介素-12等的分泌量。结果显示,与空白对照组相比,鳞柄小奥德蘑多糖能显著增强体外培养和腹腔内巨噬细胞的吞噬能力和NO合成量,增加体外培养的小鼠巨噬细胞对肿瘤坏死因子-α、白细胞介素-1、白细胞介素-6和白细胞介素-12等细胞因子的分泌量。因此,鳞柄小奥德蘑多糖可能通过提高细胞对NO和多种免疫相关信号分子的分泌量,增强细胞的吞噬能力,进而调节小鼠巨噬细胞的免疫功能。     

灵芝孢子粉免疫调节作用研究

观察DNFB诱导小鼠迟发型变态反应、血清溶血素测定（血凝法）、小鼠腹腔巨噬细胞吞噬鸡红细胞试验,结果表明,灵芝了粉可以促进小鼠细胞免疫功能提高体液免疫功能,促进小鼠体内抗体的产生,具有增强小鼠腹腔巨噬细胞吞噬功能,是一种比较有效的免疫调节剂。     

双歧杆菌及其WPG对S180荷瘤小鼠免疫调节和抑瘤的作用研究

目的 通过观察双歧杆菌及其细胞壁肽多糖（Cell Wall Preparation,whole peptidoglycon,WPG)对S180荷瘤小鼠抑瘤作用及在体内外对IL－6和TNF－α生态的影响,探讨双歧杆菌及其WOG的免疫调节和抑瘤作用机制。方法 采用经驯化而具有一定耐氧能力的两歧双歧杆菌C149株及其WPG腹腔免疫S180荷瘤小鼠,应用放射免疫检测小鼠外周血中的IL－6和TNF－α的含量,同时在体外观察小鼠腹腔巨噬细胞产生IL－6和TNF－α的影响。结果 双歧杆菌及其WPG在体内外对IL－6和TNF－α的生成有明显的促进作用,对S180荷瘤小鼠均有明显抑瘤作用。结论 双歧杆菌及其WPG可能通过刺激小鼠的巨噬细胞产生一些免疫活性因子而间接发挥抑瘤作用。     

细虫草胞外多糖对小鼠腹腔巨噬细胞免疫功能研究

本实验在体外条件下,以人工发酵培养的细虫草胞外多糖OgE、OgE-F1和OgE-F2作用于小鼠腹腔巨噬细胞RAW264.7,通过测定其对巨噬细胞的增殖率、代谢MTT活力、NO分泌和吞噬能力的影响,评价细虫草胞外多糖的免疫调节活性。结果表明,细虫草多糖对巨噬细胞无细胞毒性,且能促进巨噬细胞代谢MTT活力;在0.2mg/mL^1.0mg/mL浓度范围内,多糖呈剂量依赖性的促进巨噬细胞分泌NO水平和吞噬能力。本研究表明,细虫草多糖能有效地增强小鼠巨噬细胞的活性,潜在地可改善小鼠的先天性免疫调节。     

学龄儿童奶粉中添加食源性生物活性肽对免疫调节作用的影响

应用脂多糖（Lipopolysaccharide,LPS）诱导小鼠腹腔巨噬细胞,检测其中性红吞噬能力和NO释放量,应用刀豆蛋白A（Concanavalin A,Con A）和LPS诱导小鼠T/B淋巴细胞检测其增殖能力,通过与4种常见市售学龄儿童奶粉的免疫调节能力作比较,评价学龄儿童奶粉中添加食源性生物活性肽对的免疫调节能力。结果表明：学龄儿童奶粉中添加食源性生物活性肽对能够提高腹腔巨噬细胞的吞噬能力、NO释放量和淋巴细胞的增殖能力,说明添加食源性生物活性肽的学龄儿童奶粉具有较好的增强免疫的功能。     

仿刺参多糖抗肿瘤及对荷瘤小鼠免疫调节作用

目的 观察仿刺参多糖(AJPS)抗肿瘤及免疫调节作用.方法 采用MTT法检测AJPS对人肝癌HepG-2细胞抑制率;以Hca-F肝癌小鼠为模型,采用MTT法、放免法测定荷瘤小鼠细胞免疫指标.结果 AJPS抑制HepG-2细胞生长,抑制小鼠移植瘤生长;增强脾淋巴细胞和巨噬细胞活性,促进TNF-α和IL-2的产生.结论 AJPS具有对HepG-2细胞的直接杀伤作用;AJPS对荷瘤小鼠有免疫调节活性,在肿瘤的免疫治疗中发挥作用.     

褐藻多糖硫酸酯免疫调节和抗肿瘤活性研究

目的研究褐藻多糖硫酸酯(Fucoidan)体外抗肿瘤及免疫调节作用。方法采用MTT法检测Fu-coidan对Hca-F肝癌细胞体外生长和对正常小鼠脾淋巴细胞增殖的影响;中性红比色法检测Fucoidan对小鼠脾Mφ吞噬活性的影响;ELISA法检测Fucoidan对脾细胞细胞因子分泌水平的影响。结果浓度低于1 000μg/ml时Fu-coidan对Hca-F肝癌细胞体外生长抑制作用不明显(P0.05);Fucoidan对脾淋巴细胞增殖、Mφ吞噬活性及细胞因子IL-6、IL-10、IL-12、IL-18和TNF-α的分泌均有增加趋势。结论 Fucoidan对体外培养的小鼠Hca-F肝癌细胞生长有一定的抑制作用;可提高细胞与分子免疫应答水平,调节细胞因子分泌,发挥抗肿瘤作用。     

三生灰树花多糖胶囊通过国家检验

青岛三生生物有限公司生产的灰树花多糖胶囊日前通过山东省卫生防疫站的各项检验,该站所发的检测报告表明,该产品具有极显著的免疫调节和抑制肿瘤活性,并且具有很高的安全性。功能实验表明,口服剂量为１８ｍｇ／ｋｇ时,能显著提高小鼠的胸腺指数、抗体生成细胞数、碳粒廓清吞噬指数及腹腔巨噬细胞吞噬率,对小鼠的足跖胀度、ＮＫ细胞活性和血清溶血素无影响。提示三生灰树花多糖胶囊具有增强体液免疫功能和巨噬细胞吞噬功能的作用。同时进行的功效成分检验、稳定性试验和微生物限量检验结果表明,其主要有效成分含量高于其他同类产品,…     

Effector molecules from antitumor macrophages induced with OK-432 and cyclophosphamide

Summary The present study was designed to determine whether antitumor activity of macrophages induced with OK-432 and cyclophosphamide was mainly dependent on their ability to produce a soluble factor, that is,l-arginine-dependent nitric oxide as measured by nitrite concentration. Nitrite production by peritoneal macrophages from NIH Swiss mice pretreated with OK-432 (125 KE/kg) i.p. twice at 1-week intervals and with cyclophosphamide (200 mg/kg) i.p. 2 days before the second OK-432 treatment, increased with time for 24 h, and proportionally depended on macrophage numbers. Nitrite production was inhibited by actinomycin D and puromycin but not by mitomycin C.N ^G-Monomethyl-l-arginine, a specific competitive inhibitor ofl-arginine-dependent nitric oxide synthesis, also inhibited production. There was a close correlation between nitrite production and antitumor activity in macrophages from mice pretreated with either OK-432 and cyclophosphamide, OK-432, or thioglycolate broth. OK-432 increased both nitrite production and antitumor activities when added to the macrophage from mice pretreated with OK-432 but not with thioglycolate broth. Both activities of macrophages from mice pretreated with OK-432 and cyclophosphamide were enhanced with increasing concentrations ofl-arginine (0.125–1 mM) in the culture medium.d-Arginine, however, did not substitute forl-arginine. Neither activity was affected by contact between the macrophage and the EL4 cell. The macrophage showed antitumor activity through a membrane filter though the activity was greatly reduced. This antitumor activity of macrophages through a membrane was also inhibited byN ^G-Monomethyl-l-arginine, and increased by OK-432. However, conditioned media, obtained by culturing macrophages induced with OK-432 and cyclophosphamide, inhibited growth of EL4 cells. This activity was carried out by dialysable and non-dialysable factors. One of the dialysable factors was nitrite, an oxidized product of nitric oxide. The antitumor activity of non-dialysable factors was heat-stable and production of factors was increased byN ^G-Monomethyl-l-arginine and OK-432. Also, non-dialysable factors increased both antitumor and nitrite production activities of OK-432-elicited macrophages, when incubated with factors. Such activity of factors was also heat-stable. The production of factors increased with incubation time of macrophages, and was not inhibited byN ^G-Monomethyl-l-arginine. These results indicate that in vitro antitumor activity of macrophages induced with OK-432 and cyclophosphamide was mainly dependent onl-arginine-dependent nitric oxide, and that macrophageassociated soluble factors other than nitric oxide were also needed to inhibit fully tumor growth in vitro.     

Some biochemical and functional characteristics of macrophages activated by Tetrahymena pyriformis

Phagocytosis, enzyme activities and capacity to release hydrogen peroxide (H2O2) and superoxide anion (O2-) of peritoneal macrophages from mice inoculated with Tetrahymena pyriformis, a free-living ciliate, were examined in comparison with resident and BCG-activated macrophages. Fc receptor-mediated phagocytosis of sheep erythrocytes was markedly increased in Tetrahymena-activated macrophages to the same level as that seen in BCG-activated ones. Tetrahymena-activated macrophages showed an increased level of acid phosphatase (lysosomal enzyme) and a reduced level of alkaline phosphodiesterase I (plasma membrane ectoenzyme) as compared with resident macrophages. Similar changes in the activities of the two enzymes were also observed in BCG-activated macrophages. Both Tetrahymena- and BCG-activated macrophages exhibited more enhanced capacity to release H2O2 and O2- than resident macrophages when stimulated with phorbol myristate acetate. In the macrophages from mice inoculated with varying doses of Tetrahymena, a significant correlation was observed between the increased capacity of H2O2 and O2- release as observed in the present study, and the enhanced toxoplasmacidal activity as observed in a previous study, in a dose-dependent fashion.     

Macrophage activation by Lactobacillus casei in mice

Effects of Lactobacillus casei YIT 9018 (LC 9018), which has antitumor activities against allogeneic and syngeneic murine tumors, on macrophage functions were examined. By intraperitoneal (i.p.) injection of LC 9018, acid phosphatase activity and phagocytic activity of peritoneal macrophages were enhanced significantly compared with those of normal peritoneal macrophages. The phagocytic activities showed peaks 2-3 days after the LC 9018-injection. LC 9018 accelerated the phagocytic function of the reticuloendotherial system in ICR mice tested by the carbon clearance test. The cytostatic activity of peritoneal exudate cells (PEC) induced by i.p. injection of LC 9018 into C57BL/6 mice against EL4 cells was also enhanced. On the other hand, PEC induced by L. fermentum YIT 0159, which has no antitumor activity, did not have cytostatic activity. These observations showed that LC 9018 was able to activate macrophages in mice.     

Virulizin, a novel immunotherapy agent, activates NK cells through induction of IL-12 expression in macrophages

Virulizin, a novel biological response modifier, has demonstrated significant antitumor efficacy in a variety of human tumor xenograft models including melanoma, pancreatic cancer, breast cancer, ovarian cancer and prostate cancer. The significant role of macrophages and NK (Natural killer) cells was implicated in the antitumor mechanism of Virulizin where expansion as well as increased activity of macrophages and NK cells were observed in mice treated with Virulizin. Depletion of macrophages compromised Virulizin-induced NK1.1⁺ cell infiltration into xenografted tumors and was accompanied by reduced antitumor efficacy. In the present study, involvement of macrophages in NK cell activation was investigated further. We found that depletion of NK cells in CD-1 nude mice by anti-ASGM1 antibody significantly compromised the antitumor activity of Virulizin. Cytotoxicity of NK cells isolated from Virulizin-treated mice was enhanced against NK-sensitive YAC-1 cells and C8161 human melanoma cells, but not against NK-insensitive P815 cells. An increased level of IL-12 was observed in the serum of mice treated with Virulizin. IL-12 mRNA and protein levels were also increased in peritoneal macrophages isolated from Virulizin-treated mice. Moreover, Virulizin-induced cytotoxic activity of NK cells isolated from the spleen was abolished when an IL-12 neutralizing antibody was co-administered. In addition, depletion of macrophages in mice significantly impaired Virulizin-induced NK cell cytotoxicty. Taken together, the results suggest that Virulizin induces macrophage IL-12 production, which in turn stimulates NK cell-mediated antitumor activity.     

Activation of tumor-infiltrating macrophages by a synthetic lipid A analog (ONO-4007) and its implication in antitumor effects

ONO-4007 is a novel synthetic analog of lipid A subunit and has been shown to exert antitumor activities on various experimental tumors with less toxicity than lipopolysaccharide. It remains unclear, however, what biological activities of this compound are relevant to its antitumor effects. We therefore investigated the activation of macrophages by ONO-4007 in vitro and in vivo and its implication in antitumor effects, using mouse MM46 mammary tumor as an experimental model. Intravenous injection of ONO-4007 produced significant therapeutic effects on this solid tumor. ONO-4007 could stimulate glycogen-elicited peritoneal macrophages in vitro, not only to produce tumor necrosis factor (TNF), but also to exert cytocidal activities against MM46 cells in vitro. Substantial TNF production was induced in tumor tissue by i. v. injection of ONO-4007, and its successive administration to tumor-bearing mice gave tumor-infiltrating macrophages a prominent in vitro tumoricidal activity and primed them for in vitro TNF secretion. These results suggest that activation of tumor-infiltrating macrophages to a direct tumoricidal state as well as to TNF secretion in tumor tissues may be at least some of the antitumor effects of this novel lipid A analog.     

The augmentative effect of a protein-bound polysaccharide (PSK) on tumoricidal activity of the soluble factor produced by a streptococcal preparation (OK-432)-activated macrophages

The enhancement of antitumor activities of the tumoricidal soluble factor (SF) from a streptococcal preparation (OK-432)-activated macrophages by the pretreatment with a protein-bound polysaccharide (PSK) was investigated in tumor-bearing mice.Two-step stimulations with OK-432 atin vivo priming andin vitro eliciting were required for the production of the tumoricidal SF by macrophages, and the tumoricidal activity of the SF apparently correlated with the uptake of OK-432 by macrophages at priming phase.Tumoricidal activity of the SF from OK-432-activated macrophages in proteose-peptone (P-P)-pretreated mice significantly decreased with the development of the tumor, whereas in PSK-pretreated mice did not. Pretreatment of tumor-bearing mice with PSK saved a decrease in the macrophages carrying Ia^k or asialo GM1 antigens and an increase in wheat germ agglutinin (WGA) receptors. Furthermore, the uptake of OK-432 by macrophages at priming phase was enhanced. The tumoricidal activity of the SF from OK-432-activated macrophages was augmented.Thus, PSK may restore the depressed functions of macrophages, and the combination therapy with PSK and OK-432 may be effective to enhance the production of tumoricidal SF in tumor-bearing mice.     

A Flow Cytometric Assay Reveals a Suppression of Phagocytosis by Rabbit Defensin NP-3A in Mouse Peritoneal Macrophages

Phagocytosis of fluorescein isothiocyanate (FITC)-labeled polystyrene microparticles by peritonea] macrophages from thioglycollate-elicited mice was examined by means of flow cytometry (FCM). This assay revealed that rabbit defensin NP-3A suppressed the phagocytosis in a dose-dependent manner. The present results suggest that NP-3A released from neutrophils is one of the mediators which modulates the activity of macrophages in response to infection.     

Nonspecific stimulation of host defense by Corynebacterium kutscheri. II. Isolation of the active moiety

The isolation and determination of biological activities of the active component of Corynebacterium kutscheri were attempted in the present investigation. The antitumor effect was confined to the subcellular particle fraction of this bacterium and was associated with a molecule of glycoprotein nature (40,000-38,000 Daltons) isolated from this fraction by affinity chromatography with concanavalin A-Sepharose 4B. This substance exerted mitogenic activity on C3H/HeJ splenocytes and T cells, stimulatory activity on macrophages, and further exhibited antitumor effect on P388 leukemia in CDF1 mice. The Winn assay disclosed that the antitumor effect induced by this substance was dependent on L3T4+ T cells. Furthermore, both the mitogenic and antitumor activity of this moiety were resistant to heating at 100 degrees C for 30 min or RNase digestion, but sensitive to trypsin digestion, or low or high pH. These results indicate that the antitumor effect of C. kutscheri is attributable to the heat-stable glycoprotein moiety which can directly stimulate T cells and macrophages.     

Effect of leukocyte pyrogen on the phagocytic properties of macrophages in tissue culture]

The effect of rabbit leukocytic pyrogen (LP) on the phagocytic activity of the peritoneal macrophages of albino mice against shigellae was investigated. The dose-effect dependence was revealed: high LP doses depressed the phagocytosis, and low ones were insufficiently effective; addition of average LP doses against the kanamycin background stimulated both the absorption phase and that of shigella digestion. Phagocytosis stimulation with LP was also accompanied by an increase of the acid phosphatase lysosomal enzyme activity in macrophages; the RNA content was not changed.     

Suppression of antitumor immunity by macrophages in spleens of mice bearing a large MOPC-315 tumor

We had shown previously that progression of MOPC-315 plasmacytoma growth is associated with an increase in the percentage of macrophages in the spleen as well as a decrease in the ability of tumor-bearer spleen cells to mount an antitumor cytotoxic response upon in vitro immunization. Here we provide evidence that macrophages in the MOPC-315 tumor-bearer spleen are responsible at least in part for the suppression of the generation of antitumor cytotoxicity. Accordingly, removal of most macrophages by depletion of phagocytic cells or Sephadex G-10-adherent cells from spleens of mice bearing a large tumor resulted in augmented antitumor immune potential. Also, Sephadex G-10-adherent spleen cells from tumor-bearing (but not normal) mice drastically suppressed the in vitro generation of antitumor cytotoxicity by normal spleen cells. The suppressive activity of these adherent cells did not reside in contaminating suppressor T cells, since it was not reduced by treatment with monoclonal anti-Thy 1.2 antibody plus complement. The Sephadex G-10-adherent cell population from the tumor-bearer spleen suppressed the in vitro generation of antitumor cytotoxicity against autochthonous tumor cells but not against allogeneic EL4 tumor cells, and hence the suppression was apparently specific. The suppressive activity of the Sephadex G-10-adherent cell population from tumor-bearer spleens was overcome by treatment of the tumor-bearing mice with a low curative dose of cyclophosphamide. This immunomodulatory effect of a low dose of the drug in overcoming the suppression mediated by the Sephadex G-10-adherent cell population enables the effector arm of the immune system of tumor-bearing mice to cooperate effectively with the drug's tumoricidal activity in tumor eradication.